Please login to the form below

Not currently logged in
Email:
Password:

Bayer sends warning to doctors over Avelox

German pharma company Bayer has sent letters to doctors in Europe warning of rare incidents of severe liver and skin side effects in patients taking its antibiotic Avelox, following a routine analysis of recent data on side effects.

German pharma company Bayer has sent letters to doctors in Europe warning of rare incidents of severe liver and skin side effects in patients taking its antibiotic Avelox, following a routine analysis of recent data on side effects.

Bayer first added warnings to the Avelox label in ? 2007 but is now reinforcing it with letters.

Avelox is a prescription antibiotic that is used to treat respiratory and other infections.

"The side effects are very rare. But when it happens, it is quite severe to patients. We want doctors to be more aware," said Yvonne Moeller, a spokeswoman at Bayer told Reuters.

Avelox, one of Bayer's best-selling drugs, saw sales of almost Ä400m ($584.4 million) in 2006. In 2007, Avelox sales increased to Ä99m in Q3 2007 from Ä79m in Q3 2006.

15th February 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Access Transformation

Market Access Transformation (MAT), founded by industry veterans Baiju Aurora and Paul Howard, specializes in developing cutting edge technologies that...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics